AU2001233715A1 - Dermo- and gastro-specific sphingolipid activator - Google Patents

Dermo- and gastro-specific sphingolipid activator

Info

Publication number
AU2001233715A1
AU2001233715A1 AU2001233715A AU3371501A AU2001233715A1 AU 2001233715 A1 AU2001233715 A1 AU 2001233715A1 AU 2001233715 A AU2001233715 A AU 2001233715A AU 3371501 A AU3371501 A AU 3371501A AU 2001233715 A1 AU2001233715 A1 AU 2001233715A1
Authority
AU
Australia
Prior art keywords
dermo
gastro
sphingolipid activator
specific sphingolipid
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233715A
Other languages
English (en)
Inventor
Marcus Conradt
Kay Hofmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEMOREC MEDICAL MOLECULAR RESEARCH COLOGNE STOFFEL GmbH
Original Assignee
MEMOREC MEDICAL MOLECULAR RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEMOREC MEDICAL MOLECULAR RES filed Critical MEMOREC MEDICAL MOLECULAR RES
Publication of AU2001233715A1 publication Critical patent/AU2001233715A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU2001233715A 2000-01-26 2001-01-26 Dermo- and gastro-specific sphingolipid activator Abandoned AU2001233715A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10003154 2000-01-26
DE10003154.4 2000-01-26
PCT/EP2001/000877 WO2001055198A2 (fr) 2000-01-26 2001-01-26 Activateur de sphingolipide specifique de la peau et de l'estomac

Publications (1)

Publication Number Publication Date
AU2001233715A1 true AU2001233715A1 (en) 2001-08-07

Family

ID=7628688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233715A Abandoned AU2001233715A1 (en) 2000-01-26 2001-01-26 Dermo- and gastro-specific sphingolipid activator

Country Status (2)

Country Link
AU (1) AU2001233715A1 (fr)
WO (1) WO2001055198A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1472701A (en) * 1999-11-12 2001-06-06 Human Genome Sciences, Inc. 28 human secreted proteins
ES2402096T3 (es) * 2003-03-26 2013-04-26 Evotec International Gmbh Uso de proteínas relacionadas con saposina para prevenir y tratar la obesidad, diabetes y/o síndrome metabólico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
CA2304108A1 (fr) * 1997-09-09 1999-03-18 The Regents Of The University Of California Inhibition de l'apoptose au moyen d'agonistes du recepteur de la prosaposine
WO2000002902A1 (fr) * 1998-07-13 2000-01-20 Gill Parkash S Nouveaux inhibiteurs de l'angiogenese et de la croissance tumorale
JP2002524025A (ja) * 1998-07-23 2002-08-06 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 神経栄養因子のプロサポシンファミリーと相同性を有するヒトｓｂｐｓａｐｌ遺伝子
KR20020021775A (ko) * 1999-03-17 2002-03-22 위민즈 앤드 칠드런즈호스피틀 사포신 및 기타 마커를 사용하는 리소좀 축적 질환의 진단방법
FR2797402B1 (fr) * 1999-07-15 2004-03-12 Biomerieux Stelhys Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune

Also Published As

Publication number Publication date
WO2001055198A2 (fr) 2001-08-02
WO2001055198A9 (fr) 2003-08-14
WO2001055198A3 (fr) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2002219555A1 (en) VLA-4 Inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2002211431A1 (en) Bleed-resistant dry-transfer wallcoverings
AU2002357860A1 (en) Enzymes
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001266345A1 (en) Five-membered-ring compound
EP1151667A3 (fr) Agent d'activation de plantes
AU5248800A (en) Fading inhibitors
AU2002363129A1 (en) Collaboration-enabled enterprise
AU2001239765A1 (en) Novel compounds
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001246998A1 (en) Novel compounds
AU2001241098A1 (en) Composition
AU2002347778A1 (en) Enzymes
AU2001275201A1 (en) Acne-treating composition
AU2001230689A1 (en) Novel compounds
AU2001287852A1 (en) Composition
AU2002337150A1 (en) Microchamber
AU2001233715A1 (en) Dermo- and gastro-specific sphingolipid activator
AUPQ575300A0 (en) New compound
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001223878A1 (en) Sealant
AU2001262163A1 (en) Composition
AU2001237533A1 (en) Novel p-gp-inhibiting compounds